Overview

Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function

Status:
Unknown status
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Erythropoietin Treatment in Patients with systolic left ventricular dysfunction, mild anemia and normal renal function
Phase:
Phase 4
Details
Lead Sponsor:
Rabin Medical Center
Treatments:
Epoetin Alfa